Barbat Skullcap

Description

Barbat skullcap (Scutellaria barbata, ban zhi lian) is a very bitter herb with a long history of use in Traditional Chinese Medicine for the treatment of cancer, tumors, bacterial infections and hepatitis.

Recent research demonstrated Barbat skullcap to be among the top 5 most effective herbs for eliminating stationary phase Bartonella henselae.  It has also been shown to be a potent antimicrobial for antibiotic resistant Staphylococcus aureus (MRSA).

It is a potent anti-oxidant, anti-mutagenic, and liver protective herb, and has been demonstrated to halt the growth of cancer cells.  It is also anti-viral and anti-inflammatory (modulating various inflammatory pathways).

It is non-toxic, and has no reported side effects.

 

Ingredients:

Scutellaria barbata, distilled water, and certified organic cane alcohol.

Made with plant material on which no pesticide residues were detected upon testing

Recommended Dose: 

1-3 ml / 2x / day in 2 oz water.

Synergistic Combinations Include:
– For treatment of Bartonella infection, take alongside Lucid Liposomal Essential Oil Remedy, and Bart-None tincture formula.  

 

Shipping and Returns Information

 

Sources:

Goh D, Lee YH, Ong ES. Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo. J Agric Food Chem 2005; 53(21):8197-8204.

Gong T, Wang CF, Yuan JR, et al. Inhibition of Tumor Growth and Immunomodulatory Effects of Flavonoids and Scutebarbatines of Scutellaria barbata D. Don in Lewis-Bearing C57BL/6 Mice. Evid Based Complement Alternat Med. 2015;2015:630760.

 

Ma, Xiao1; Leone, Jacob2; Schweig, Sunjya3; Zhang, Ying4. Botanical Medicines With Activity Against Stationary Phase Bartonella henselae. Infectious Microbes & Diseases 3(3):p 158-167, September 2021. | DOI: 10.1097/IM9.0000000000000069

 

Sato Y, et al. Phytochemical flavones isolated from Scutellaria barbata and antibacterial activity against methicillin-resistant Staphylococcus aureus. J Ethnopharmacol 2000; 72(3):483-488.

Tsai TY, Livneh H, Hung TH, et al. Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study. BMJ open. Jan 25 2017;7(1):e014571.